News Release

Immune system cells protect against CMV-induced hearing loss in mice

Natural killer cells recognize and bind to viral protein on surface of infected inner ear cells

Peer-Reviewed Publication

PLOS

Immune System Cells Protect Against CMV-Induced Hearing Loss in Mice

image: Ly49H blockade induces co-localization of mCMV-GFP infected cells and NK cells within the temporal bone. view more 

Credit: Almishaal AA, et al. (2017)

Immune system cells known as natural killer (NK) cells play an important protective role against hearing loss in mice infected with cytomegalovirus (CMV), according to a new study published in PLOS Pathogens.

Mothers may pass CMV to babies during pregnancy, putting them at greater risk for long-term hearing loss. CMV is responsible for 15-30% of hearing loss in children. Previous studies have shown that NK cells, which kill infected cells to control viral infections, interact with a specific CMV protein called m157 at the surface of infected mouse cells. However, it was unknown whether this interaction is important in CMV-induced hearing loss.

To determine the significance of the interaction between NK cells and m157, Ali Almishaal of the University of Utah College of Health and colleagues performed experiments in mice. They used previously developed techniques to mimic many of the features of CMV-induced hearing loss in children.

The researchers used mice bred to lack a functional version of the protein Ly49H, a receptor protein found on the surface of NK cells that recognizes and binds to m157. After infection with CMV, these mice developed profound hearing loss and lost a significant amount of outer hair cells, which are found in the ear and play an important role in hearing. In contrast, CMV-infected mice with functional Ly49H had minimal loss of hearing and hair cells.

To further confirm the importance of the interaction between Ly49H and m157, the research team used an antibody to block Ly49H activity in a third group of CMV-infected mice. They also infected a fourth group with a CMV strain lacking the gene that codes for m157. Both groups were more susceptible to hearing loss than mice with normal Ly49H/m157 interaction.

These results confirm the importance of the Ly49H/m157 interaction in protecting against hearing loss in CMV-infected mice. This interaction was previously shown to play an important role in protecting against CMV effects in the mouse spleen and lung, but is less effective in the liver.

While their findings provide new insights into the mechanisms of CMV-induced hearing loss, the authors say that efforts to prevent hearing loss by targeting NK cell activity are unlikely to be successful without far better understanding of NK cell activity in utero and in newborns.

"The study demonstrates the importance of the innate immune response in controlling CMV-induced hearing loss. We expect that further characterization of this response will ultimately lead to identification of novel effective clinical interventions." Albert Park, MD, the study's senior author adds.

###

In your coverage please use this URL to provide access to the freely available article in PLOS Pathogens: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006599

Citation: Almishaal AA, Mathur PD, Hillas E, Chen L, Zhang A, Yang J, et al. (2017) Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice. PLoS Pathog 13(8): e1006599. https://doi.org/10.1371/journal.ppat.1006599

Funding: This work was supported in part by a 2013 Career Development Award from the Triological Society (http://www.triological.org/researchgrants.html) to AHP, by National Institute of Health (https://projectreporter.nih.gov/project_info_details.cfm?aid=8826125&icde=32115046&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC) grant EY020853 to JY and grants from National Institute of Health (EY014800) (https://projectreporter.nih.gov/project_info_details.cfm?aid=9123599&icde=32115066&ddparam=&ddvalue=&ddsub=&cr=5&csb=default&cs=ASC) and the Research to Prevent Blindness Fund (https://www.rpbusa.org/rpb/grants-and-research/grants/current-grant-recipients/institutional-grantees/) for support of imaging facilities. WMY is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.